Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Arpinati, Mario  [Clear All Filters]
Journal Article
Cristiano G, Nanni J, Sartor C, Parisi S, Marconi G, Barbato F, Arpinati M, Bonifazi F, Curti A, Cavo M, et al. Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement. Acta Haematol. 2021:1-5.
Delia M, Carluccio P, Mestice A, Chiusolo P, Metafuni E, Bellesi S, Arpinati M, Milone GAntonio, Martino M, Mazza P, et al. The impact of graft CD3/Tregs ratio on aGvHD and post-transplant outcome: a prospective multicenter study on patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation. Transplant Cell Ther. 2021.
Pellegrini M, Bernabei F, Barbato F, Arpinati M, Giannaccare G, Versura P, Bonifazi F. Incidence, risk factors and complications of ocular graft-versus-host disease following hematopoietic stem cell transplantation: Incidence, risk factors and complications of ocular GVHD. Am J Ophthalmol. 2021.
Bernabei F, Versura P, Pellegrini M, Moscardelli F, Bonifazi F, Sessa M, Arpinati M, Scorcia V, Giannaccare G. Longitudinal Analysis of Infrared Meibography in Patients Undergoing Hematopoietic Stem Cell Transplantation. Cornea. 2020.
Marconi G, Talami A, Abbenante MChiara, Sartor C, Parisi S, Nanni J, Bertamini L, Ragaini S, Olivi M, de Polo S, et al. Mec (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplantat in acute myeloid leukemia. Eur J Haematol. 2020.